This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Inventor Xing Li
Introduction
Xing Li is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of genetic disorders. His work focuses on developing innovative solutions that can improve the quality of life for individuals affected by rare diseases.
Latest Patents
Xing Li holds a patent for "Adeno associated virus vectors for the treatment of Hunter disease." This patent describes a recombinant adeno-associated virus (rAAV) vector that includes an AAV8 or AAV9 capsid and a codon-optimized sequence encoding a human iduronate-2-sulfatase (I2S) enzyme. The method outlined in the patent involves administering this rAAV vector to a subject with Hunter syndrome (MPS II), resulting in an increase in I2S enzymatic activity in the subject.
Career Highlights
Xing Li is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work at Takeda emphasizes the importance of innovative therapies in addressing unmet medical needs.
Collaborations
Xing Li collaborates with various professionals in the field, including his coworker Vivian Choi. Together, they work on projects that aim to enhance the understanding and treatment of genetic disorders.
Conclusion
Xing Li's contributions to biotechnology and his innovative patent for treating Hunter syndrome highlight his commitment to improving patient outcomes. His work exemplifies the impact of dedicated inventors in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile